With the Food and Drug Administration (FDA) still under fire for failing to monitor the safety of a popular diabetes drug after it hit the market, researchers have released a new study revealing ...
Washington, DC - Public Citizen, the Washington, DC-based consumer advocacy group founded by Ralph Nader, has petitioned the FDA to immediately ban the "unacceptably dangerous" prescription diet drug ...
Medicare does not cover sibutramine (Meridia) or other drugs prescribed for weight loss. However, Medicare Part D prescription drug plans and Medicare Advantage (Part C) plans may cover prescription ...
Meridia (sibutramine) is a medication that, along with diet and exercise, can help treat obesity related to high cholesterol, diabetes, and high blood pressure. However, this medication is no longer ...
Meridia is marketed by North Chicago-based Abbott Laboratories. The company has previously stressed that the drug is only approved for patients with no previous history of heart disease. FDA approved ...
The strongly worded editorial comes two weeks before government advisers review the prescription drug, which has already been pulled in Europe. In January, U.S. drug regulators strengthened existing ...
When the diet drug Meridia was approved by the Food and Drug Administration more than a decade ago, the American Heart Association was quick to urge caution, stressing that the medication—which works ...
LOS ANGELES - The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the ...
LOS ANGELES, Aug 6 (Reuters) - Abbott Laboratories' weight loss drug Meridia will be reviewed by an advisory panel to the U.S. Food and Drug Administration on September 15, the company said on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results